Proteochemometrics - recent developments in bioactivity and selectivity modeling.
暂无分享,去创建一个
Adriaan P IJzerman | Brandon J Bongers | Gerard J P Van Westen | G. V. van Westen | A. IJzerman | B. Bongers
[1] Arzucan Özgür,et al. DeepDTA: deep drug–target binding affinity prediction , 2018, Bioinform..
[2] B. Rasti,et al. Proteochemometric modeling of the origin of thymidylate synthase inhibition , 2018, Chemical biology & drug design.
[3] A. Bender,et al. Prediction of PARP Inhibition with Proteochemometric Modelling and Conformal Prediction , 2015, Molecular informatics.
[4] Jahan B. Ghasemi,et al. Probing the origin of dihydrofolate reductase inhibition via proteochemometric modeling , 2018, Journal of Chemometrics.
[5] B. Rasti,et al. Structural insights into the origin of phosphoinositide 3-kinase inhibition , 2020, Structural Chemistry.
[6] David Vidal,et al. Evaluation of Cross-Validation Strategies in Sequence-Based Binding Prediction Using Deep Learning , 2019, J. Chem. Inf. Model..
[7] Isidro Cortes-Ciriano,et al. Polypharmacology modelling using proteochemometrics (PCM): recent methodological developments, applications to target families, and future prospects , 2015 .
[8] Jia Zhang,et al. Computational drug repositioning using collaborative filtering via multi-source fusion , 2017, Expert Syst. Appl..
[9] Knut Baumann,et al. Reliable estimation of prediction errors for QSAR models under model uncertainty using double cross-validation , 2014, Journal of Cheminformatics.
[10] George Papadatos,et al. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound–Kinase Activities: A Way toward Selective Promiscuity by Design? , 2016, J. Chem. Inf. Model..
[11] Anne E Carpenter,et al. Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery. , 2018, Cell chemical biology.
[12] Isidro Cortes-Ciriano,et al. Improved large-scale prediction of growth inhibition patterns using the NCI60 cancer cell line panel , 2015, Bioinform..
[13] Jahan B. Ghasemi,et al. Quantitative Characterization of the Interaction Space of the Mammalian Carbonic Anhydrase Isoforms I, II, VII, IX, XII, and XIV and their Inhibitors, Using the Proteochemometric Approach , 2016, Chemical biology & drug design.
[14] Gianni De Fabritiis,et al. KDEEP: Protein-Ligand Absolute Binding Affinity Prediction via 3D-Convolutional Neural Networks , 2018, J. Chem. Inf. Model..
[15] Peteris Prusis,et al. Improved approach for proteochemometrics modeling: application to organic compound - amine G protein-coupled receptor interactions , 2005, Bioinform..
[16] Hao Ding,et al. Collaborative matrix factorization with multiple similarities for predicting drug-target interactions , 2013, KDD.
[17] Zachary Wu,et al. Learned protein embeddings for machine learning , 2018, Bioinformatics.
[18] Noel Southall,et al. Novel Consensus Architecture To Improve Performance of Large-Scale Multitask Deep Learning QSAR Models , 2019, J. Chem. Inf. Model..
[19] Isidro Cortes-Ciriano,et al. Benchmarking of protein descriptor sets in proteochemometric modeling (part 2): modeling performance of 13 amino acid descriptor sets , 2013, Journal of Cheminformatics.
[20] Volkan Atalay,et al. DEEPScreen: high performance drug–target interaction prediction with convolutional neural networks using 2-D structural compound representations† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c9sc03414e , 2020, Chemical science.
[21] Maria Liakata,et al. Merits of random forests emerge in evaluation of chemometric classifiers by external validation. , 2013, Analytica chimica acta.
[22] Gerard J. P. van Westen,et al. Benchmarking of protein descriptor sets in proteochemometric modeling (part 1): comparative study of 13 amino acid descriptor sets , 2013, Journal of Cheminformatics.
[23] Gerard J. P. van Westen,et al. Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets , 2011 .
[24] A. Linusson,et al. Quantitative protein descriptors for secondary structure characterization and protein classification , 2009 .
[25] M. A. Sarram,et al. A novel proteochemometrics model for predicting the inhibition of nine carbonic anhydrase isoforms based on supervised Laplacian score and k-nearest neighbour regression , 2018, SAR and QSAR in environmental research.
[26] Julian E. Fuchs,et al. 3D proteochemometrics: using three-dimensional information of proteins and ligands to address aspects of the selectivity of serine proteases. , 2017, MedChemComm.
[27] Sergey Plis,et al. Deep Learning Applications for Predicting Pharmacological Properties of Drugs and Drug Repurposing Using Transcriptomic Data. , 2016, Molecular pharmaceutics.
[28] Isidro Cortes-Ciriano,et al. Prediction of the potency of mammalian cyclooxygenase inhibitors with ensemble proteochemometric modeling , 2015, Journal of Cheminformatics.
[29] P. Garg,et al. An improved approach for predicting drug-target interaction: proteochemometrics to molecular docking. , 2016, Molecular bioSystems.
[30] Nanda Ghoshal,et al. Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening. , 2015, Molecular bioSystems.
[31] Yonghua Wang,et al. Pred-binding: large-scale protein–ligand binding affinity prediction , 2016, Journal of enzyme inhibition and medicinal chemistry.
[32] George Papadatos,et al. Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set , 2017, bioRxiv.
[33] Jarl E. S. Wikberg,et al. Kinome-wide interaction modelling using alignment-based and alignment-independent approaches for kinase description and linear and non-linear data analysis techniques , 2010, BMC Bioinformatics.
[34] Isidro Cortes-Ciriano,et al. Proteochemometric modelling coupled to in silico target prediction: an integrated approach for the simultaneous prediction of polypharmacology and binding affinity/potency of small molecules , 2015, Journal of Cheminformatics.
[35] Dingfeng Wu,et al. Finding the molecular scaffold of nuclear receptor inhibitors through high-throughput screening based on proteochemometric modelling , 2018, Journal of Cheminformatics.
[36] Sabrina Jaeger,et al. Mol2vec: Unsupervised Machine Learning Approach with Chemical Intuition , 2018, J. Chem. Inf. Model..
[37] Simone Fulle,et al. Kinome‐Wide Profiling Prediction of Small Molecules , 2018, ChemMedChem.
[38] Benoit Playe,et al. Evaluation of deep and shallow learning methods in chemogenomics for the prediction of drugs specificity , 2020, Journal of Cheminformatics.
[39] John P. Overington,et al. Identification of Allosteric Modulators of Metabotropic Glutamate 7 Receptor Using Proteochemometric Modeling , 2017, J. Chem. Inf. Model..
[40] Gerard J. P. van Westen,et al. Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling , 2019, Journal of Cheminformatics.
[41] Irini Doytchinova,et al. Proteochemometrics-Based Prediction of Peptide Binding to HLA-DP Proteins , 2017, J. Chem. Inf. Model..
[42] I. Doytchinova,et al. Peptide Binding Prediction to Five Most Frequent HLA‐DQ Proteins – a Proteochemometric Approach , 2015, Molecular informatics.
[43] Zhiwei Cao,et al. Study on human GPCR-inhibitor interactions by proteochemometric modeling. , 2013, Gene.
[44] T. Lundstedt,et al. Development of proteo-chemometrics: a novel technology for the analysis of drug-receptor interactions. , 2001, Biochimica et biophysica acta.
[45] Shaoming Yang,et al. Applying chemometrics approaches to model and predict the binding affinities between the human amphiphysin SH3 domain and its peptide ligands. , 2010, Protein and peptide letters.
[46] C. Nantasenamat,et al. Exploring the origin of phosphodiesterase inhibition via proteochemometric modeling , 2017 .
[47] Andreas Bender,et al. Prospectively Validated Proteochemometric Models for the Prediction of Small-Molecule Binding to Bromodomain Proteins , 2018, J. Chem. Inf. Model..
[48] O. Spjuth,et al. Origin of aromatase inhibitory activity via proteochemometric modeling , 2016, PeerJ.
[49] Hyunwhan Joe,et al. Multi-channel PINN: investigating scalable and transferable neural networks for drug discovery , 2019, Journal of Cheminformatics.
[50] G. Schneider,et al. Active learning for computational chemogenomics. , 2017, Future medicinal chemistry.
[51] George M. Church,et al. Unified rational protein engineering with sequence-based deep representation learning , 2019, Nature Methods.